Generic vs. Brand-Name Drugs: Same Active Ingredient, Different Inactive Ingredients

A generic drug has to match the brand-name drug in the ways that make it work: the same active ingredient, strength, dosage form, and route, and it has to be bioequivalent. For most pills and capsules, it does not have to match the brand’s inactive ingredients. That means two versions of the same medicine, or two generics from different companies, can contain different fillers, dyes, and flavors, and so can differ in the allergens they contain. For injectables and eye and ear products, the rules are much stricter, with a few named exceptions.

None of this makes generics a lesser product. It means that if you react to a specific inactive ingredient, the name of the drug is not enough information. The version in your hand is.

What a generic has to match

Most prescription drugs sold in the US are generics, and the FDA holds every one of them to the same core test. A company applying to sell a generic must show that its product has:

• The same active ingredient as the brand-name drug it copies.
• The same strength, dosage form, and route: a 10 mg tablet taken by mouth is compared with a 10 mg tablet taken by mouth.
• Bioequivalence, which the FDA describes as delivering the same amount of active ingredient at the same rate and to the same extent as the brand.
• The same labeling, with certain permitted exceptions, including differences that come from being made by a different manufacturer.

Notice what is missing from that list: the fillers, binders, coatings, colors, and flavors that make up the rest of the product.

What a generic does not have to match

The FDA’s own definition of equivalent products says it plainly. Drug products that share the same active ingredient, amount, dosage form, and route “do not necessarily contain the same inactive ingredients,” and they may differ in shape, scoring, packaging, and excipients, including colors, flavors, and preservatives. For tablets and capsules, the generic maker must identify and characterize its inactive ingredients and show that they do not affect the safety or effectiveness of the product. It does not have to use the brand’s recipe.

This applies between generics too. There are often several approved generics for one brand-name drug, and that definition covers all of them. So a generic from one company and a generic from another can use different fillers from each other as well as from the brand.

The FDA’s position is that in most cases these differences do not matter clinically, but that in a minority of patients, inactive ingredients may affect tolerability. It also will not approve a generic whose inactive ingredients are unsafe under the conditions in its labeling. Both statements are true at once. For the general population, a different filler is a non-event. For someone with a milk, corn, or dye sensitivity, it is the whole question, which is why our guide to hidden ingredients exists.

Where the rules require a closer match

Federal regulations for generic applications set tighter inactive-ingredient rules for certain kinds of products. Each rule starts with the word “generally,” and each lists what may still differ:

• Injectables (parenteral products). A generic generally must contain the same inactive ingredients, in the same concentration, as the brand. It may differ in preservative, buffer, or antioxidant, if the maker shows the difference does not affect safety or effectiveness.
• Eye and ear products (ophthalmic and otic). The same rule, with preservative, buffer, tonicity agent, or thickening agent allowed to differ. For eye products, a buffer or tonicity change cannot be used to claim an advantage over the brand.
• Topical products, nasal solutions, and solutions for nebulization. These generally must contain the same inactive ingredients as the brand, but a generic may include different ones if the maker identifies them and shows they do not affect safety or effectiveness. There is no same-concentration requirement here.

Authorized generics: the brand’s product without the brand name

There is one kind of generic that starts from the brand itself. An authorized generic is the brand-name drug product marketed without the brand name on its label, sold either by the brand company or by another company with its permission. The FDA describes it as the same drug product as the brand, sometimes sold at a lower price. One caution from the FDA’s own description: an authorized generic tablet or capsule may have a different color or marking. So if you tolerate the brand, an authorized generic is worth asking about, and still worth checking.

What this means for you

• Ask which manufacturer made it. Your pharmacist can tell you whose version you are getting. That, not the drug name, is what determines the inactive ingredients.
• Keep a record of the version you tolerate. Write down the manufacturer and the NDC number, so you can ask for the same one next time and spot a change when it happens. Our guide on why your refill looks different covers what to do when the pill in the bottle changes.
• Read the inactive ingredients for each new version. Our guide on how to read a drug label shows where to find them for over-the-counter and prescription products.
• Do not stop a medication on your own. If a new version worries you, review it with your pharmacist or prescriber first.
• Check the exact product in the app. The AllergenMeds app flags ingredients like these in the exact product you look up.

This guide is for education only, not medical advice. Always talk to your doctor or pharmacist before starting, stopping, or switching any medication.